Immunisation with live attenuated Salmonella dublin expressing a sporozoite protein confers partial protection against Theileria parva

Vaccine

Volumn 16, Issue 8, 1998, Pages 834-841

  Heussler, V T ^a   Taracha, E L N ^b   Musoke, A ^b   Duchateau, L ^b   McKeever, D J ^b  

^a Dept for Zoo and Wildlife Pathology   (Switzerland)

^b INTERNATIONAL LIVESTOCK RESEARCH INSTITUTE   (Kenya)

Author keywords

Attenuated Salmonella; Recombinant antigen; Theileria parva

Indexed keywords

LIVE VACCINE; MEMBRANE ANTIGEN;

ANIMAL CELL; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CATTLE; CONTROLLED STUDY; GENE EXPRESSION; IMMUNIZATION; INTRAMUSCULAR DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; SALMONELLA DUBLIN; T LYMPHOCYTE; THEILERIA PARVA;

ANIMALS; ANTIBODIES, PROTOZOAN; BACTERIAL VACCINES; CATTLE; CD4-POSITIVE T-LYMPHOCYTES; IMMUNITY, CELLULAR; PROTOZOAN PROTEINS; RECOMBINANT FUSION PROTEINS; SALMONELLA; SPECIES SPECIFICITY; THEILERIA PARVA; THEILERIASIS; VACCINATION; VACCINES, ATTENUATED; VACCINES, SYNTHETIC;

EID: 0032078204     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(97)00263-6     Document Type: Article

References (32)

1. 1 Shaw, M.K., Tilney, L.G. and Musoke, A.J. The entry of Theileria parva sporozoites into bovine lymphocytes: evidence for MHC class I involvement. Journal of Cell Biology 1991, 113, 87
2. 2 Morrison W.I., Lalor P.A., Goddeeris B.M. et al. Theileriosis: antigens and host-parasite interactions. In: Parasite Antigens, Towards New Strategies for Vaccines (Ed. Pearson, T.W.). Marcel Dekker Inc., New York, 1985, p. 167
3. 3 McKeever, D.J. and Morrison, W.I. Theileria parva: the nature of the immune response and its significance for immunoprophylaxis. Reviews in Science and Technology 1990, 9, 405
4. 4 Musoke, A.J., Nantulya, V.M., Buscher, G., Masake, R.A. and Otim, B. Bovine immune responses to Theileria parva: neutralizing antibodies to sporozoites. Immunology 1982, 45, 663
5. 5 Musoke, A., Morzaria, S., Nkonge, C., Jones, E. and Nene, V. A recombinant sporozoite surface antigen of Theileria parva induces protection in cattle. Proceedings of the National Academy of Science USA 1992, 89, 514
6. 6 Londono, L.P., Chatfield, S. and Tindle, R.W. et al. Immunisation of mice using Salmonella typhimurium expressing human papillomavirus type 16 E7 epitopes inserted into hepatitis B virus core antigen. Vaccine 1996, 14, 545
7. 7 Dunne, M., al Ramadi, B.K., Barthold, S.W., Flavell, R.A. and Fikrig, E. Oral vaccination with an attenuated Salmonella typhimurium strain expressing Borrelia burgdorferi OspA prevents murine Lyme borreliosis. Infection and Immunity 1995, 63, 1611
8. 8 Hone, D.M., Lewis, G.K. and Beier, M. et al. Expression of human immunodeficiency virus antigens in an attenuated Salmonella typhi vector vaccine. Developmental Biology Standards 1994, 82, 159
9. 9 Xu, D., McSorley, S.J., Chatfield, S.N., Dougan, G. and Liew, F.Y. Protection against Leishmania major infection in genetically susceptible BALB/c mice by gp63 delivered orally in attenuated Salmonella typhimurium (AroA AroD). Immunology 1995, 85, 1
10. 10 Segall, T. and Lindberg, A.A. Experimental oral Salmonella dublin infection in calves. A bacteriological and pathological study. Zentralblatt? Veterinaermedizin B 1991, 38, 169
11. 11 Nene, V., Iams, K.P., Gobright, E. and Musoke, A.J. Characterisation of the gene encoding a candidate vaccine antigen of Theileria parva sporozoites. Molecular Biochemistry and Parasitology 1992, 51, 17
12. 12 Katende, J.M., Gooderies, B.M., Morzaria, S.P., Nkonge, C.G. and Musoke, A.J. Identification of a Theileria mutans-specific antigen for use in an antibody and antigen detection ELISA. Parasite Immunology 1990, 12, 419
13. 13 Goddeeris, B., Morrison, I., Teale, A., Bensaid, A. and Baldwin, C. Bovine cytotoxic T-cell clones specific for cells infected with the protozoan parasite Theileria parva: parasite strain specificity and class I major histocompatibility complex restriction. Proceedings of the National Academy of Science USA 1986, 83, 5238
14. 14 Norval R.A.I, Perry B.P. and Young A.S. (Eds) The Epidemiology of Theileriosis in Africa. Academic Press, San Diego, 1992, p.236
15. 15 Tsai, C. and Frasch, C.E. A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels. Analytical Biochemistry 1982, 119, 115
16. 16 Chatfield, S.N., Roberts, M. and Dougan, G. et al. The development of oral vaccines against parasitic diseases utilizing live attenuated Salmonella. Parasitology 1995, 110, (Suppl.), S17
17. 17 Curtiss, R. Jr. III, Kelly, S.M. and Tinge, S.A. et al. Recombinant Salmonella vectors in vaccine development. Developmental Biology Standards 1994, 82, 23
18. 18 Dougan, G., Hormaeche, C.E. and Maskell, D.J. Live oral Salmonella vaccines: potential use of attenuated strains as carriers of heterologous antigens to the immune system. Paraste Immunology 1987, 9, 151
19. 19 Fairweather, N.F., Chatfield, S.N. and Makoff, A.J. et al. Oral vaccination of mice against tetanus by use of a live attenuated Salmonella carrier. Infection and Immunity 1990, 58, 1323
20. 20 Fouts, T.R., Lewis, G.K. and Hone, D.M. Construction and characterization of a Salmonella typhi-based human immunodeficiency virus type 1 vector vaccine. Vaccine 1995, 13, 561
21. 21 Aggarwal, A., Kumar, S. and Jaffe, R. et al. Oral Salmonella: malaria circumsporozoite recombinants induce specific CD8+ cytotoxic T cells. Journal of Experimental Medicine 1990, 172, 1083
22. 22 Stabel, T.J., Mayfield, J.E., Morfitt, D.C. and Wannemuehler, M.J. Oral immunisation of mice and swine with an attenuated Salmonella choleraesuis [delta cya-12 delta(crp-cdt)19] mutant containing a recombinant plasmid. Infection and Immunity 1993, 61, 610
23. 23 Chatfield, S.N., Charles, I.G. and Makoff, A.J. et al. Use of the nirB promoter to direct the stable expression of heterologous antigens in Salmonella oral vaccine strains: development of a single-dose oral tetanus vaccine. Bio/Technology 1992, 10, 888
24. 24 Redman, T.K., Harmon, C.C., Lallone, R.L. and Michalek, S.M. Oral immunisation with recombinant Salmonella typhimurium expressing surface protein antigen A of Streptococcus sobrinus: dose-response and induction of protective humoral responses in rats. Infection and Immunity 1995, 63, 2004
25. 25 Strugnell, R.A., Maskell, D. and Fairweather, N. Stable expression of foreign antigens from the chromosome of Salmonella typhimurium vaccine strains. Gene 1990, 88, 57
26. 26 Turner, S.J., Carbone, F.R. and Strugnell, R.A. Salmonella typhimurium delta aroA delta aroD mutants expressing a foreign recombinant protein induce specific major histocompatibility complex class I-restricted cytotoxic T lymphocytes in mice. Infection and Immunity 1993, 61, 5374
27. 27 Tijhaar, E.J., Zheng-Xin, Y. and Karlas, J.A. et al. Construction and evaluation of an expression vector allowing the stable expression of foreign antigens in a Salmonella typhimurium vaccine strain. Vaccine 1994, 12, 1004
28. 28 DeMartini, J.C. and Baldwin, C.L. Effects of gamma interferon, tumor necrosis factor alpha, and interleukin-2 on infection and proliferation of Theileria parva-infected bovine lymphoblasts and production of interferon by parasitized cells. Infection and Immunity 1991, 59, 4540
29. 29 Goddeeris, B.M., Morrison, I.W., Naessens, J. and Magondu, J.G. The bovine autologous mixed leukocyte reaction: a proliterative response of non-T cells under the control of monocytes. Immunobiology 1987, 176, 47
30. 30 Bacher, B., Metz, C.N. and Calandra, T. An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proceedings of the National Academy of Science USA 1996, 93, 7849
31. 31 Cardenas, L., Dasgupta, U. and Clements, J.D. Influence of strain viability and antigen dose on the use of attenuated mutants of Salmonella as vaccine carriers. Vaccine 1994, 12, 833
32. 32 Burridge, M.J. and Kimber, C.D. Effect of humoral antibodies on the course of Theileria parva (East Coast fever) infection of cattle. American Journal of Veterinary Research 1975, 36, 399